Combination antiretroviral therapy has dramatically increased the life expectancy for patients infected with HIV. However, the prevalence of HIV-associated neurocognitive disorders, which may be triggered by inflammation in the central nervous system, has substantially risen. A new study in the iJournal of Clinical Investigation/i suggests that a host protein, heme oxygenase-1, is protective against HIV-associated inflammation and cognitive decline. Dennis ...Monday 15 September 2014
Host Protein Protective Against HIV-Associated Inflammation
Combination antiretroviral therapy has dramatically increased the life expectancy for patients infected with HIV. However, the prevalence of HIV-associated neurocognitive disorders, which may be triggered by inflammation in the central nervous system, has substantially risen. A new study in the iJournal of Clinical Investigation/i suggests that a host protein, heme oxygenase-1, is protective against HIV-associated inflammation and cognitive decline. Dennis ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment